Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials
Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into co...
Saved in:
| Published in | BMC psychiatry Vol. 12; no. 1; p. 78 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
12.07.2012
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials.
We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome.
The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact.
When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. |
|---|---|
| AbstractList | Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m.sup.2 reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Doc number: 78 Abstract Background: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. Methods: We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. Results: The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m2 reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. Conclusions: When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. Methods We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. Results The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m.sup.2 reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. Conclusions When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Keywords: Body weight, randomised clinical trials, physical health promotion, intervention, meta-analysis, psychosis Abstract Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. Methods We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. Results The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a −0.98 kg/m2 reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. Conclusions When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Background: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. Methods: We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. Results: The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m super(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. Conclusions: When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. BACKGROUND: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials. METHODS: We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome. RESULTS: The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a −0.98 kg/m2 reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact. CONCLUSIONS: When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials.BACKGROUNDPsychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature cardiovascular disease. A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation. It takes into consideration not only risks such as gender, age, and family history that are inherently non-modifiable, but also those such as obesity, smoking, diabetes, hypertension, and dyslipidemia that are modifiable through behavioural changes and improved care. Thus, it is crucial to focus on factors that increase cardiovascular risk. Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications. The present systematic review and meta-analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in randomised clinical trials.We systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome.METHODSWe systematically reviewed the randomised controlled trials from 1990 onward, in which psychoeducational and/or cognitive-behavioural interventions aimed at weight loss or prevention of weight gain in patients with psychosis had been compared to treatment as usual. We carried out a meta-analysis and pooled the results of the studies with Body Mass Index as primary outcome.The results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact.RESULTSThe results of the meta-analysis show an effect toward the experimental group. At the end of the intervention phase there is a -0.98 kg/m(2) reduction in the mean Body Mass Index of psychotic subjects. Notably, prevention studies with individual psychoeducational programmes that include diet and/or physical activity seem to have the highest impact.When compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders.CONCLUSIONSWhen compared with treatment as usual in psychotic patients, preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight. Physical screening and monitoring programmes are well accepted by patients and can be implemented in a variety of settings. A weight loss of 0.98 points in the Body Mass Index corresponds to a loss of 3.12% of the initial weight. This percentage is below the 5% to 10% weight loss deemed sufficient to improve weight-related complications such as hypertension, type II diabetes, and dyslipidemia. However, it is reported that outcomes associated with metabolic risk factors may have greater health implications than weight changes alone. Therefore, in addition to weight reduction, the assessment of metabolic parameters to monitor other independent risk factors should also be integrated into physical health promotion and management in people with mental disorders. |
| ArticleNumber | 78 |
| Audience | Academic |
| Author | Bonfioli, Elena Goss, Claudia Muraro, Francesca Burti, Lorenzo Berti, Loretta |
| AuthorAffiliation | 1 Department of Public Health and Community Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy |
| AuthorAffiliation_xml | – name: 1 Department of Public Health and Community Medicine, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy |
| Author_xml | – sequence: 1 givenname: Elena surname: Bonfioli fullname: Bonfioli, Elena – sequence: 2 givenname: Loretta surname: Berti fullname: Berti, Loretta – sequence: 3 givenname: Claudia surname: Goss fullname: Goss, Claudia – sequence: 4 givenname: Francesca surname: Muraro fullname: Muraro, Francesca – sequence: 5 givenname: Lorenzo surname: Burti fullname: Burti, Lorenzo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22789023$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk01r3DAQhk1JaT7ac29F0EsvTiRLtuQeCmlok0CglxZ6E7I83tUiW1vJu2H_Rn9xx9l8bUig6CAx885j-Z3RYbY3hAGy7D2jx4yp6oQJyfJCiN85K3KpXmUH95G9R-f97DClBaVMqpK9yfaLQqqaFvwg-3sBxo9zsoyhD6MLA_GugzRuPBA3jBDXMEzhRLoQyTW42XwkvRnMDHrMoIYs08bOQ3LpMzEkbdIIvRmdJRHWDq6JGVrSw2hyLPIblJHQkYjR0LsELbFhGGPwHo9jdMant9nrDjd4d7sfZb--f_t5dpFf_Ti_PDu9yptKVGMum4ZRClzwjneN4cpYDrQo2s40wirT1kVLJVe2Up0yRWVq0zasamQrwcqq5EfZ5ZbbBrPQy-h6Ezc6GKdvAiHOtIn4Ix60UKwEW1RUNlYwyupa8EpazlUpFC0BWV-2rOWq6aG1aE00fge6mxncXM_CWvNS1FJJBHzdAhoXXgDsZmzo9dRfPfVXs0JLhZBPt7eI4c8Ku6jRYgvemwHCKqFKlbSucAz-Qyq5VGjnRP34RLoIq4jNvFGxqlBUlg-qmUHD3NAFvKadoPq05IKVtZLTZ4-fUeFqoXc4CdA5jO8UfHhs7L0hdxOMgnIrsDGkFKHT1o1mGlkkO68Z1dNLecarkyd1d-iXKv4BSZwXTA |
| CitedBy_id | crossref_primary_10_7570_kjo_2015_24_3_156 crossref_primary_10_1017_S1368980022000969 crossref_primary_10_1111_ppc_12516 crossref_primary_10_1007_s00038_016_0807_y crossref_primary_10_1016_j_psychres_2014_06_035 crossref_primary_10_1192_bjp_bp_115_177139 crossref_primary_10_1146_annurev_clinpsy_032813_153657 crossref_primary_10_3310_NFIZ5916 crossref_primary_10_1111_ppc_12071 crossref_primary_10_1002_wps_20130 crossref_primary_10_1007_s00406_018_0941_z crossref_primary_10_47493_abantmedj_1069336 crossref_primary_10_1016_j_jad_2017_03_003 crossref_primary_10_3389_fpsyt_2024_1382676 crossref_primary_10_1186_s12888_018_1692_0 crossref_primary_10_3322_caac_21334 crossref_primary_10_1136_bmjopen_2020_040387 crossref_primary_10_1002_pnp_830 crossref_primary_10_1136_bmjopen_2022_068652 crossref_primary_10_3389_fpsyt_2022_903759 crossref_primary_10_1016_j_schres_2017_06_017 crossref_primary_10_1111_inm_12214 crossref_primary_10_1186_s12913_020_5059_0 crossref_primary_10_1016_j_genhosppsych_2014_11_005 crossref_primary_10_1186_s12913_019_4608_x crossref_primary_10_1016_j_schres_2020_05_049 crossref_primary_10_1186_s12888_023_05409_0 crossref_primary_10_1016_j_neubiorev_2021_01_005 crossref_primary_10_1186_s12888_016_0763_3 crossref_primary_10_1007_s15005_020_1327_0 crossref_primary_10_1111_inm_12301 crossref_primary_10_1038_mp_2012_175 crossref_primary_10_1007_s11845_021_02576_5 crossref_primary_10_1016_S2215_0366_15_00213_8 crossref_primary_10_1177_0020764016629494 crossref_primary_10_1080_15487768_2016_1231643 crossref_primary_10_1080_14999013_2023_2214381 crossref_primary_10_1159_000502293 crossref_primary_10_1097_MJT_0000000000000708 crossref_primary_10_3390_nu15092136 crossref_primary_10_1111_jocn_12782 crossref_primary_10_1007_s00115_023_01534_z crossref_primary_10_1186_s12888_015_0465_2 crossref_primary_10_1111_jhn_12473 crossref_primary_10_1007_s00213_017_4763_x crossref_primary_10_1017_S0033291714003110 crossref_primary_10_1038_s41366_022_01063_w crossref_primary_10_1186_s12888_021_03575_7 crossref_primary_10_3389_fpsyt_2024_1343427 crossref_primary_10_1002_hpja_377 crossref_primary_10_3390_ph14030238 crossref_primary_10_1111_eip_12913 crossref_primary_10_1016_j_schres_2018_06_066 crossref_primary_10_1111_ppc_12391 crossref_primary_10_1111_inm_12246 crossref_primary_10_1080_01612840_2018_1440450 crossref_primary_10_1371_journal_pone_0136603 crossref_primary_10_1002_wps_20614 crossref_primary_10_5498_wjp_v11_i10_696 crossref_primary_10_1080_01612840_2019_1642426 crossref_primary_10_1111_inm_12373 crossref_primary_10_1097_YCO_0000000000000618 crossref_primary_10_1016_j_schres_2018_07_033 crossref_primary_10_1176_appi_ps_201300576 crossref_primary_10_1186_s13643_022_02067_3 crossref_primary_10_3390_nu14235012 crossref_primary_10_1002_oby_22567 crossref_primary_10_1097_NMD_0000000000000803 crossref_primary_10_1111_1747_0080_12754 crossref_primary_10_2174_1871525718666200518093418 crossref_primary_10_1016_j_euroneuro_2019_12_118 crossref_primary_10_1016_j_whi_2016_05_001 crossref_primary_10_1007_s00406_023_01684_w crossref_primary_10_1097_NMD_0000000000000036 crossref_primary_10_1186_s13063_020_4112_y crossref_primary_10_1186_s13063_016_1176_9 crossref_primary_10_1377_hlthaff_2015_0791 crossref_primary_10_1016_j_apnu_2023_06_008 crossref_primary_10_1016_j_schres_2023_09_036 crossref_primary_10_1186_s13643_022_01912_9 crossref_primary_10_1016_j_eurpsy_2016_11_008 crossref_primary_10_12968_bjmh_2016_5_6_262 crossref_primary_10_1111_inm_12343 crossref_primary_10_1002_cl2_1070 crossref_primary_10_1016_j_pnpbp_2013_05_005 crossref_primary_10_1176_appi_focus_19103 crossref_primary_10_15256_joc_2017_7_107 crossref_primary_10_1007_s11920_012_0347_y crossref_primary_10_3109_01612840_2015_1092187 crossref_primary_10_3389_fpsyt_2018_00488 crossref_primary_10_7570_jomes23016 crossref_primary_10_1371_journal_pone_0112276 crossref_primary_10_3310_pgfar07020 crossref_primary_10_1186_s12913_021_07126_4 crossref_primary_10_1111_eip_12546 crossref_primary_10_1016_j_apnu_2017_08_005 crossref_primary_10_30699_ajnmc_29_4_328 crossref_primary_10_1097_NMD_0000000000001081 crossref_primary_10_1016_j_jagp_2014_07_007 crossref_primary_10_11124_JBISRIR_2017_003943 crossref_primary_10_1186_s12889_018_5649_5 crossref_primary_10_11124_JBISRIR_2016_003121 |
| Cites_doi | 10.1016/j.schres.2007.05.022 10.1016/j.eatbeh.2005.08.003 10.2337/diacare.27.2.596 10.4088/JCP.v69n0401 10.3109/09638230802522460 10.1016/S0924-9338(10)71705-3 10.1016/j.euroneuro.2006.06.005 10.1002/j.2051-5545.2011.tb00014.x 10.1016/j.schres.2006.01.008 10.1176/ajp.156.11.1686 10.1002/j.2051-5545.2011.tb00036.x 10.4088/JCP.v67n0405 10.1038/nrendo.2010.121 10.1080/13651500902763840 10.1016/j.psc.2004.09.008 10.1177/0269881105058682 10.1111/j.1467-789X.2008.00547.x 10.4088/JCP.v66n0208 10.1016/j.schres.2009.09.039 10.1016/j.schres.2006.12.025 10.1016/S0025-7125(05)70230-3 10.4088/JCP.v67n0812 10.1080/08039480801985179 10.1016/S0924-9338(10)71700-4 10.1111/j.1467-789X.2009.00570.x 10.1111/j.1547-5069.2003.00237.x 10.1016/S0924-9338(10)71699-0 10.1080/10401230500464646 10.1177/070674370104600610 10.1136/bmj.327.7414.557 10.1016/j.schres.2009.10.012 10.1017/S1121189X00003407 10.1097/01.jcp.0000237943.57893.e6 10.1007/BF02850000 10.1176/ps.2007.58.4.544 10.2975/29.2005.122.127 10.1192/bjp.bp.107.042853 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2012 BioMed Central Ltd. 2012 Bonfioli et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Bonfioli et al.; licensee BioMed Central Ltd. 2012 Bonfioli et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Bonfioli et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Bonfioli et al.; licensee BioMed Central Ltd. 2012 Bonfioli et al.; licensee BioMed Central Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
| DOI | 10.1186/1471-244X-12-78 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Proquest Medical Database Psychology Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database Neurosciences Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-244X |
| EndPage | 78 |
| ExternalDocumentID | oai_doaj_org_article_4815ec2607bc4101994367c33854805e PMC3549787 oai_biomedcentral_com_1471_244X_12_78 2870673221 A534159877 22789023 10_1186_1471_244X_12_78 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GroupedDBID | --- 0R~ 23N 2VQ 2WC 4.4 53G 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AZQEC BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DWQXO E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPNFZ IPY ITC KQ8 M1P M2M M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PSYQQ RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 -A0 ABVAZ ACRMQ ADINQ AFGXO AFNRJ C24 5PM PUEGO |
| ID | FETCH-LOGICAL-b646t-7bb100e343f3fba38ac3e022dfab4c8ad92d0738c68f8a26a9adb16b7d7ec7653 |
| IEDL.DBID | RBZ |
| ISSN | 1471-244X |
| IngestDate | Wed Aug 27 01:27:56 EDT 2025 Thu Aug 21 18:30:03 EDT 2025 Wed May 22 07:14:52 EDT 2024 Fri Jul 11 10:00:54 EDT 2025 Fri Jul 11 05:04:08 EDT 2025 Fri Jul 25 07:43:27 EDT 2025 Tue Jun 17 22:05:31 EDT 2025 Mon Jul 21 10:57:45 EDT 2025 Mon Jul 21 05:31:52 EDT 2025 Tue Jul 01 01:46:16 EDT 2025 Thu Apr 24 23:04:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | http://www.springer.com/tdm This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b646t-7bb100e343f3fba38ac3e022dfab4c8ad92d0738c68f8a26a9adb16b7d7ec7653 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | http://dx.doi.org/10.1186/1471-244X-12-78 |
| PMID | 22789023 |
| PQID | 1271628075 |
| PQPubID | 44775 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4815ec2607bc4101994367c33854805e pubmedcentral_primary_oai_pubmedcentral_nih_gov_3549787 biomedcentral_primary_oai_biomedcentral_com_1471_244X_12_78 proquest_miscellaneous_1285096017 proquest_miscellaneous_1273780228 proquest_journals_1271628075 gale_infotracmisc_A534159877 gale_infotracacademiconefile_A534159877 pubmed_primary_22789023 crossref_citationtrail_10_1186_1471_244X_12_78 crossref_primary_10_1186_1471_244X_12_78 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-07-12 |
| PublicationDateYYYYMMDD | 2012-07-12 |
| PublicationDate_xml | – month: 07 year: 2012 text: 2012-07-12 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC psychiatry |
| PublicationTitleAlternate | BMC Psychiatry |
| PublicationYear | 2012 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | TA Wadden (1160_CR40) 2005; 28 LF Van Gaal (1160_CR5) 2006; 16 GS Skrinar (1160_CR28) 2005; 29 WW Fleischacker (1160_CR1) 2008; 64 C Samele (1160_CR9) 2004; 13 AL Montejo (1160_CR43) 2010; 25 Y Khazaal (1160_CR20) 2007; 91 S Evans (1160_CR14) 2005; 39 American Diabetes Association American Psychiatric Association American Association of Clinical Endocrinologists North American Association for the Study of Obesity (1160_CR6) 2004; 27 S Brown (1160_CR26) 2009; 18 T Wu (1160_CR36) 2009; 10 MK Wu (1160_CR21) 2007; 58 W Milano (1160_CR30) 2007; 24 DB Allison (1160_CR4) 2009; 36 G Faulkner (1160_CR11) 2007 M Alvarez Jiménez (1160_CR10) 2008; 193 P Scocco (1160_CR18) 2006; 7 M Jean-Baptiste (1160_CR29) 2007; 96 M De Hert (1160_CR2) 2011; 10 M De Hert (1160_CR45) 2011; 10 D Allison (1160_CR8) 1999; 156 S Coodin (1160_CR23) 2001; 46 M Alvarez Jiménez (1160_CR15) 2006; 67 T Veit (1160_CR33) 2009; 13 JS Kwon (1160_CR16) 2006; 67 CL McKibbin (1160_CR17) 2006; 121 KH Littrell (1160_CR12) 2003; 35 KA Forsberg (1160_CR31) 2008; 62 CL McKibbin (1160_CR39) 2010; 121 C Loh (1160_CR7) 2006; 18 M Mauri (1160_CR32) 2008; 26 R Ganguli (1160_CR27) 2005; 31 C Bushe (1160_CR41) 2005; 19 IB Chaudhry (1160_CR44) 2010; 25 1160_CR24 M Weber (1160_CR19) 2006; 83 JS Brar (1160_CR13) 2005; 66 JPT Higgins (1160_CR25) 2003; 327 M Alvarez Jiménez (1160_CR38) 2010; 116 TA Wadden (1160_CR34) 2000; 84 ML Vetter (1160_CR35) 2010; 6 CW Colton (1160_CR42) 2006; 3 A Heald (1160_CR3) 2010; 25 JM Gabriele (1160_CR37) 2009; 10 World Health Organization (1160_CR22) 2010 |
| References_xml | – volume: 96 start-page: 198 year: 2007 ident: 1160_CR29 publication-title: Schizophr Res doi: 10.1016/j.schres.2007.05.022 – volume: 7 start-page: 115 year: 2006 ident: 1160_CR18 publication-title: Eat Behav doi: 10.1016/j.eatbeh.2005.08.003 – volume: 27 start-page: 596 issue: 2 year: 2004 ident: 1160_CR6 publication-title: Diabetes Care doi: 10.2337/diacare.27.2.596 – volume: 64 start-page: 514 issue: 4 year: 2008 ident: 1160_CR1 publication-title: J Clin Psychiatry doi: 10.4088/JCP.v69n0401 – volume: 18 start-page: 372 issue: 5 year: 2009 ident: 1160_CR26 publication-title: J Ment Health doi: 10.3109/09638230802522460 – volume: 25 start-page: S37 issue: Suppl 2 year: 2010 ident: 1160_CR44 publication-title: Eur Psychiatry doi: 10.1016/S0924-9338(10)71705-3 – ident: 1160_CR24 – volume: 16 start-page: S142 year: 2006 ident: 1160_CR5 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2006.06.005 – volume: 10 start-page: 52 year: 2011 ident: 1160_CR2 publication-title: World Psychiatry doi: 10.1002/j.2051-5545.2011.tb00014.x – volume: 83 start-page: 95 year: 2006 ident: 1160_CR19 publication-title: Schizophr Res doi: 10.1016/j.schres.2006.01.008 – volume: 156 start-page: 1686 year: 1999 ident: 1160_CR8 publication-title: Am J Psychiatry doi: 10.1176/ajp.156.11.1686 – volume: 10 start-page: 138 issue: 2 year: 2011 ident: 1160_CR45 publication-title: World Psychiatry doi: 10.1002/j.2051-5545.2011.tb00036.x – volume: 67 start-page: 547 issue: 4 year: 2006 ident: 1160_CR16 publication-title: J Clin Psychiatry doi: 10.4088/JCP.v67n0405 – volume: 6 start-page: 578 issue: 10 year: 2010 ident: 1160_CR35 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2010.121 – volume: 13 start-page: 173 issue: 3 year: 2009 ident: 1160_CR33 publication-title: Int J Psychiatry Clin Pract doi: 10.1080/13651500902763840 – volume: 36 start-page: 341 issue: 4 year: 2009 ident: 1160_CR4 publication-title: A National Institute of Mental Health meeting report. Am J Prev Med – volume: 28 start-page: 151 year: 2005 ident: 1160_CR40 publication-title: Psychiatr Clin N Am doi: 10.1016/j.psc.2004.09.008 – volume: 19 start-page: Supplement:28 issue: 6 year: 2005 ident: 1160_CR41 publication-title: J Psychopharmacol doi: 10.1177/0269881105058682 – volume-title: Cochrane Database Syst Rev year: 2007 ident: 1160_CR11 – volume: 10 start-page: 313 year: 2009 ident: 1160_CR36 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2008.00547.x – volume: 66 start-page: 205 issue: 2 year: 2005 ident: 1160_CR13 publication-title: J Clin Psychiatry doi: 10.4088/JCP.v66n0208 – volume: 121 start-page: 203 year: 2006 ident: 1160_CR17 publication-title: Schizophr Res doi: 10.1016/j.schres.2009.09.039 – volume: 91 start-page: 169 year: 2007 ident: 1160_CR20 publication-title: Schizophr Res doi: 10.1016/j.schres.2006.12.025 – volume: 84 start-page: 441 issue: 2 year: 2000 ident: 1160_CR34 publication-title: Med Clin North Am doi: 10.1016/S0025-7125(05)70230-3 – volume: 39 start-page: 479 year: 2005 ident: 1160_CR14 publication-title: Aust N Z J Psychiatry – volume: 67 start-page: 1253 issue: 8 year: 2006 ident: 1160_CR15 publication-title: J Clin Psychiatry doi: 10.4088/JCP.v67n0812 – volume: 31 start-page: 561 year: 2005 ident: 1160_CR27 publication-title: Schizophr Bull – volume: 62 start-page: 486 issue: 6 year: 2008 ident: 1160_CR31 publication-title: Nord J Psychiatry doi: 10.1080/08039480801985179 – volume: 25 start-page: S6 issue: Suppl 2 year: 2010 ident: 1160_CR3 publication-title: Eur Psychiatry doi: 10.1016/S0924-9338(10)71700-4 – volume: 10 start-page: 442 year: 2009 ident: 1160_CR37 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2009.00570.x – volume: 35 start-page: 237 issue: 3 year: 2003 ident: 1160_CR12 publication-title: J Nurs Scholarsh doi: 10.1111/j.1547-5069.2003.00237.x – volume: 25 start-page: S3 issue: Suppl 2 year: 2010 ident: 1160_CR43 publication-title: Eur Psychiatry doi: 10.1016/S0924-9338(10)71699-0 – volume: 18 start-page: 23 issue: 1 year: 2006 ident: 1160_CR7 publication-title: Ann Clin Psychiatry doi: 10.1080/10401230500464646 – volume: 46 start-page: 549 year: 2001 ident: 1160_CR23 publication-title: Can J Psychiatry doi: 10.1177/070674370104600610 – volume: 327 start-page: 557 year: 2003 ident: 1160_CR25 publication-title: Br Med J doi: 10.1136/bmj.327.7414.557 – volume: 121 start-page: 203 year: 2010 ident: 1160_CR39 publication-title: Schizophr Res doi: 10.1016/j.schres.2009.09.039 – volume: 116 start-page: 16 year: 2010 ident: 1160_CR38 publication-title: Schizophr Res doi: 10.1016/j.schres.2009.10.012 – volume: 13 start-page: 141 issue: 3 year: 2004 ident: 1160_CR9 publication-title: Epidemiol Psichiatr Soc doi: 10.1017/S1121189X00003407 – volume: 26 start-page: 462 issue: 5 year: 2008 ident: 1160_CR32 publication-title: J Clin Psychopharmacol doi: 10.1097/01.jcp.0000237943.57893.e6 – volume: 24 start-page: 123 issue: 1 year: 2007 ident: 1160_CR30 publication-title: Adv Ther doi: 10.1007/BF02850000 – volume: 58 start-page: 544 issue: 4 year: 2007 ident: 1160_CR21 publication-title: Psychiatr Serv doi: 10.1176/ps.2007.58.4.544 – volume: 29 start-page: 122 issue: 2 year: 2005 ident: 1160_CR28 publication-title: Psychiatr Rehabil J doi: 10.2975/29.2005.122.127 – volume-title: International Statistical Classification of Diseases and Related Health Problems 10th Revision year: 2010 ident: 1160_CR22 – volume: 193 start-page: 101 year: 2008 ident: 1160_CR10 publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.107.042853 – volume: 3 start-page: 1 issue: 2 year: 2006 ident: 1160_CR42 publication-title: Prev Chronic Dis |
| SSID | ssj0017851 |
| Score | 2.3567066 |
| SecondaryResourceType | review_article |
| Snippet | Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to premature... Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to... Doc number: 78 Abstract Background: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general... Background: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to... BACKGROUND: Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due primarily to... Abstract Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population, due... |
| SourceID | doaj pubmedcentral biomedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 78 |
| SubjectTerms | Age Body Mass Index Body weight Cardiovascular diseases Care and treatment Clinical trials Cognitive Behavioral Therapy - methods Cognitive Behavioral Therapy - statistics & numerical data Diabetes mellitus Diabetes therapy Diets Dyslipidemia Health promotion Health Promotion - methods Humans Hypertension intervention Life span Mental disorders Mentally ill meta-analysis Methods Neuroleptics Obesity Obesity - complications Obesity - therapy Patient Education as Topic Patient outcomes Physical activity physical health promotion Psychiatry Psychoses Psychosis Psychotic Disorders - complications Psychotic Disorders - therapy randomised clinical trials Randomized Controlled Trials as Topic Reviews Risk factors Risk Reduction Behavior Side effects Smoking Systematic review Weight loss Weight Reduction Programs - methods Weight Reduction Programs - statistics & numerical data |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYKgl7ptkyapnlZxWYT15MK7hXwVH7xtF_sW8d_wL3YmzasvLOrF26OZ0DTz68zkdeY3hLysOt_YEFRZ2Z6V3LeqVN6r0oVWOG4tbyNd09lncXrOP63a1V6rL8wJm-mB5407QjKR4CDqltZxwE_XcSakg5MVMpW1Aa0v-LzdYSp9P8CW87GuSNYlOLBVIvWplTharmFSAnZXywrdN5l_ijT-1431nrfKMyn3XNPJHXI7xZT0eH6Wu-RGGO6Rm2fpq_l98nOuNaKXc-rdONDNuocb_NgEut7LeZwoRLD0e_yzlF4seTEgQ-dirWk9vaWG_mZ_pnPlCzWDpxdha0qTOE7o2FPwgn4EGAVPU0L8Bn7GNiHTA3J-8vHLh9My9WIoreBiW0pr66oKjLOe9dYwZRwL4P99byx3yviu8WAtlBOqV6YRpjPe1sJKL4OTomUPycEwDuExoY3nFWxYE5gS3NfWhLrvPGtM8BJU6QvyLtOIvpx5NzQyYecj8FJq1KdGfeq60VIV5M1Of9olmnPstrHR8bijxPUJr5cJuzv9UfQ9AiJbULwAgNUJsPpfgC3IK4STRgMCC3Mm1UHA5iAVlz5uIbBoOyVlQQ4zSdCYy4d3gNTJ8EywTqQEQ4bpgrxYhnEmJtMNYbyKMkxiibX6m4xCYiB4kwryaMb48thz9XTDCiIz9Gf7ko8M66-Rupy12NFQPvkfG_mU3ILoNeZO180hOdh-uwrPIELc2ufRGPwCGS1kHw priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9JYKgL_W2SZuk-iCneBzC-eTBvoV8VRf22vW6h_hv-Bc7k2b3Nhze27KZ0DQzmUnS3_yGkNez1jMbgipntuNl7RtVKu9V6UIjXG1t3US6ppNv4vi0_jpv5unCbUywyo1PjI7aDw7vyA8qhlxHSJ37cfWrxKpR-HU1ldC4SW4hdRlCuuR8e-CKhecTnU-lxEEFjriEcDZHOALWVctS3JdZZIoE_lfd9E6cyjGUO0Hp6B65m3aT9HBS_31yI_QPyO2T9L38Ifk7ZRnR1QS6G3q6XHTwgD_LQBc7aMeRwt6V_o7XpPRsi4gBGTqlaY2L8T019JL3mU45L9T0np6FtSlNYjehQ0ch_vkBDCh4mqDwS_gZC4SMj8jp0Zfvn4_LVIWhtKIW61JaW81mgde84501XBnHA0R-3xlbO2V8yzz4CeWE6pRhwrTG20pY6WVwUjT8Mdnrhz48JZT5egYTxgJXovaVNaHqWs-ZCV4ysJqCfMg0olcT44ZGDuy8BUxDoz416lNXTEtVkHcb_WmXCM6xzsZSx4OOElc7vN122Dzpv6Kf0CCyAcU_hvMfOq1xjbw3wcEBUVpXg6tr25oL6ThXSKrXhIK8QXPS6DpgYM6kDAiYHCTh0ocNbCmaVklZkP1MEjTm8uaNQerkckZ9uUAK8mrbjD0RRteH4SLKcInJ1eo6GYWUQLB6CvJksvHta09504wXRGbWn81L3tIvfkbSct5gLUP57PqhPyd3YEca8dAV2yd76_OL8AJ2fWv7Mi7tfyI8W8E priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgL4k2gICMhwSVlYzu2A0KoIKoKaTmx0t4svwIrpUnZbAX9G_xixo73EVo4cYvW48Q7D884mfkGoeeTyhHjvcwnpqY5c6XMpXMyt77klhnDygjXNP3Mj2fs07ycb9sBJQb2lx7tQj-p2bI5-Pn9_B0Y_Nto8JK_KmCDzcFNzUOagZBX0TVwSyJY6ZRtPymELvSx1CgRJ5yfS27wR-17M3JZEdn_4v6948DGyZU73uroFrqZwkx8OOjFbXTFt3fQ9Wn6kH4X_RrKj_DpkI3XtbhZ1PCA88bjxU4aZI8hqMU_4vtTfLJJlQEaPNRv9Yv-NdZ4CwiNh2IYrFuHT_xK5zrBnuCuxuAYXQea5R1OOfINXMbOIf09NDv6-OXDcZ7aM-SGM77KhTHFZOIpozWtjaZSW-ohJHC1NsxK7SriYAORlstaasJ1pZ0puBFOeCt4Se-jvbZr_UOEiWMTYBjxVHLmCqN9UVeOEu2dIKBOGXozkog6HaA4VADHHo-AnaogTxXkqQqihMzQwVp-yibk89CAo1HxBCT5xQkvNxPWT_or6fugEKMFxR-65VeVjF8FQBxv4eQojGWwB1YVo1xYSmVA2yt9hl4EdVJBy2FhVqfSCGBOQOdShyXEGmUlhcjQ_ogSJGbHw2uFVGtTgnUGlLAAOp2hZ5vhMDPk17W-O4s0VISqa_kvGhmwgsCSMvRg0PHN3x4KqgnNkBhp_4gv45F28S2imdMyNDkUj_4HIx-jGxDQxnTqguyjvdXyzD-BoHFlnsbN4DeaWmwp priority: 102 providerName: Scholars Portal |
| Title | Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22789023 https://www.proquest.com/docview/1271628075 https://www.proquest.com/docview/1273780228 https://www.proquest.com/docview/1285096017 http://dx.doi.org/10.1186/1471-244X-12-78 https://pubmed.ncbi.nlm.nih.gov/PMC3549787 https://doaj.org/article/4815ec2607bc4101994367c33854805e |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA_eHYgv4rfVc4kg6Et1m6RJqk-3csch7CHiweJLyFe5hb32sHuI_4Z_sZM029veqS--LGUzadPMZGbSzPwGoVfTyhHjvcynpqY5c6XMpXMyt77klhnDygjXND_hx6fs06JcXIFFXzvBLyR_V4D6zMEILUIQgZA7aI8wMINhYz77NhwYhBrzMZEoEScUnz_c4Fpm-2pkkCJu_03tvGWexqGTW7bo6B66m5xIfNBz_T665ZsH6PY8HZM_RL_65CJ80cfatQ1eLWt4wM-Vx8utIMcOg8uKf8Svo_h8CIQBGtxnZ3XL7j3W-AruGfepLlg3Dp_7tc51AjXBbY3B7LkW5MY7nCLgV3AZ64J0j9Dp0eHXj8d5Kr6QG874OhfGFNOpp4zWtDaaSm2pB4Pvam2YldpVxIF6kJbLWmrCdaWdKbgRTngreEkfo92mbfxThIljU5gw4qnkzBVG-6KuHCXaO0FAWDL0YcQRddEDbagAfT1ugVWoAj9V4KcqiBIyQ283_FM24ZqH8horFfc3kt_s8GbosHnSX0lnQSBGA4p_gICqtLRVgLvxFvaFwlgGGq6qGOXCwt4_YOmVPkOvgzipoDFgYFanxAeYnIC9pQ5K8CTKSgqRof0RJXDMjps3AqmSpulgnAEDLEBKZ-jl0Bx6hui5xreXkYaKkFMt_0UjAxIQrKQMPellfHjtPl2a0AyJkfSP5mXc0izPIlY5LUMJQ_Hsv1j8HN0BPzVGSRdkH-2uv1_6F-ALrs0E7YiFmKC92eHJ5y-T-EUFfudMTqJ--A3WP2MX |
| linkProvider | BioMedCentral |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemTgJeEP8JDDASCF7CGjuJHRBCG2zq2FohtEl9M_4XqNQlZek07WvwQfiM3CVp12hib3ur6rPi-H6-s-O73xHyqp85ZryXYd_kPIxdIkPpnAytT1IbGxMnNV3TcJQOjuKv42S8Rv4ucmEwrHJhE2tD7UqL38g3I4ZcR0id-2n2O8SqUXi7uiih0cBi35-fwZGt-rj3BfT7mrHdncPPg7CtKhCaNE7noTAm6vc9j3nOc6O51JZ78GQu1ya2UruMOcC9tKnMpWapzrQzUWqEE96KFKtEgMlfjzkcZXpkfXtn9O378t4CS923BEKRTDcjMP0hONAxBkBgJbdOUv204wvrkgGXHcOKZ-xGba64wd075Ha7f6VbDeDukjVf3CM3hu0N_X3yp8lrorMmzK8s6HSSwwPOp55OVuIrKwq7ZXpWf5ilx8sYHJChTWJYNaneU00vmKZpk2VDdeHosZ_rULd8KrTMKXhcVwJkvaNt8P0UftYlSaoH5OhaNPSQ9Iqy8I8JZS7uw4Qxz2Uau8hoH-WZ40x7JxjgNCAfOhpRs4bjQyHrdrcFwKhQnwr1qSKmhAzIu4X-lG0p1bGyx1TVRyuZXu7wdtlh8aT_im4jIDoDqv8oT36q1qooZNrxFo6kwtgYjGuWASyF5VwijV_iA_IG4aTQWMHArG5zLmBykPZLbSWwiUkyKURANjqSoDHbbV4AUrVGrlIXSzIgL5fN2BMD9wpfntYyXGA6t7xKRiIJEayegDxqML587SZTm_GAiA76O_PSbSkmv2qadJ5g9UTx5OqhvyA3B4fDA3WwN9p_Sm7BfriOxo7YBunNT079M9hzzs3zdqFT8uO6bcs_wL6bkg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSBUXxLuBAkZCgkvaTfwMnFpgVR6tEKJSxcXyK7Aim6y6WyH-Br-YsePdbihw4RbF4yTr-Twz2cx8g9CTUeVK473MR6YmOXVM5tI5mVvPuKXGUBbpmg6P-MExfXvCThKlUKiFMVN7nua7s16C3kS7DQf22-7M1f12l3y3APOag5M6CUkGQl5GVwRjIuzRj_ufVx8UQg_6WGiUhBPLzx8u8FvlezNwWJHX_6L1XnNfw9TKNV81vo6upSAT7_WouIEu-fYm2jxMn9FvoZ998RGe9bl4XYubSQ03-NF4PFlLgpxjCGnx9_jvKZ6uEmVABvfVW_PJ_DnW-JwOGvelMFi3Dk_9Quc6kZ7grsbgFl0HuPIOpwz5Bg5j35D5bXQ8fv3p5UGemjPkhlO-yIUxxWjkCSU1qY0mUlviISBwtTbUSu2q0oH5kJbLWuqS60o7U3AjnPBWcEbuoI22a_0WwqWjI1iw0hPJqSuM9kVdOVJq70QJYMrQi4FG1Kwn4lCBGns4AhBRQZ8q6FMVpRIyQztL_SmbeM9D-41GxfcfyS9OeLaasLzTX0X3AyAGDxRPdKdfVNr6KtDheAvvjcJYChawqijhwhIiA9ce8xl6GuCkgkUJ8NapMAIWJ3BzqT0GkQarpBAZ2h5IgsbscHgJSJUs0RyeM3CEBcrpDD1eDYeZIbuu9d1ZlCEi1FzLf8nIwBQEOylDd3uMr352X05dkgyJAfoH6zIcaSdfI5c5YaHFobj3Xyp-hDY_vBqr92-O3t1HVyGkjQnVRbmNNhanZ_4BhI0L8zAahF9H4W5W |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Health+promotion+lifestyle+interventions+for+weight+management+in+psychosis%3A+a+systematic+review+and+meta-analysis+of+randomised+controlled+trials&rft.jtitle=BMC+psychiatry&rft.au=Bonfioli+Elena&rft.au=Berti+Loretta&rft.au=Goss+Claudia&rft.au=Muraro+Francesca&rft.date=2012-07-12&rft.pub=BMC&rft.issn=1471-244X&rft.eissn=1471-244X&rft.volume=12&rft.issue=1&rft.spage=78&rft_id=info:doi/10.1186%2F1471-244X-12-78&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4815ec2607bc4101994367c33854805e |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-244X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-244X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-244X&client=summon |